Group One Trading’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Group One Trading’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,794	Closed	-$92K	–	6437
2020 Q1	$92K	Hold	5,794	–	–	﹤0.01%	3365
2019 Q4	$94K	Buy	+5,794	New	+$96.6K	﹤0.01%	3681

Group One Trading's CBMG Position: Q2 2020 in Review

Group One Trading sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q2 2020, closing a stake of 5,794 shares — an estimated $92K sold.

Group One Trading first reported a position in CBMG in Q4 2019 and held it in 2 quarters. The position peaked at $94K in Q4 2019. 45 funds tracked by Wall St. Rank hold CBMG as of Q2 2020.

Group One Trading reported no remaining Cellular Biomedicine Group, Inc. position as of Q2 2020 after selling out during the quarter.
Group One Trading sold 5,794 Cellular Biomedicine Group, Inc. shares in Q2 2020, an estimated $92K.
Group One Trading first reported a position in Cellular Biomedicine Group, Inc. in Q4 2019 and held it in 2 quarters.
Group One Trading's Cellular Biomedicine Group, Inc. position peaked at $94K in Q4 2019.
45 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q2 2020.

Based on Group One Trading's 13F filing for Q2 2020, filed 13 Aug 2020.